Patent · US Active

Method of treating androgen receptor negative prostate tumors and their metastases

US10517933B2 · kind B2 · utility

0Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2016
Grant dateDec 31, 2019
Priority date
Expiry dateMay 11, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/723
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention includes a method of preventing or treating metastasis in a subject diagnosed with prostate cancer. In certain embodiments, the metastasis comprises bone cancer. In other embodiments, the subject suffers from castration-resistant prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.